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Abstract
Infections by Neisseria meningitidis show duality between frequent asymptomatic carriage and occasional life-threatening
disease. Bacterial and host factors involved in this balance are not fully understood. Cytopathic effects and cell damage may
prelude to pathogenesis of isolates belonging to hyper-invasive lineages. We aimed to analyze cell–bacteria interactions
using both pathogenic and carriage meningococcal isolates. Several pathogenic isolates of the ST-11 clonal complex and
carriage isolates were used to infect human epithelial cells. Cytopathic effect was determined and apoptosis was scored
using several methods (FITC-Annexin V staining followed by FACS analysis, caspase assays and DNA fragmentation). Only
pathogenic isolates were able to induce apoptosis in human epithelial cells, mainly by lipooligosaccharide (endotoxin).
Bioactive TNF-a is only detected when cells were infected by pathogenic isolates. At the opposite, carriage isolates seem to
provoke shedding of the TNF-a receptor I (TNF-RI) from the surface that protect cells from apoptosis by chelating TNF-a.
Ability to induce apoptosis and inflammation may represent major traits in the pathogenesis of N. meningitidis. However,
our data strongly suggest that carriage isolates of meningococci reduce inflammatory response and apoptosis induction,
resulting in the protection of their ecological niche at the human nasopharynx.
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Introduction
Neisseria meningitidis is the causative agent of meningococcal
meningitis and fulminant sepsis. It is a common inhabitant of the
human nasopharynx, being asymptomatically carried by approx-
imately 10% of the population, worldwide. The incidence of
meningococcal disease varies from 1 to 50 cases per 100,000. The
reported fatality rate in meningococcal meningitis is about 10%
and up to 20% of survivors suffer from sequelae [1]. While in
industrialized countries, meningococcal disease occurs usually as
sporadic cases, large epidemics occur periodically in the
‘‘meningitis belt’’ of sub-Saharan Africa (from Senegal to
Ethiopia). There is increasing evidence that invasive meningococ-
cal infections
lead to cytopathic effects that often result in marked tissue and
cell damage mainly characterized by the breakdown of cell tight
junctions, the deterioration of the cell layers, changes in normal
cell morphology, and loss of cells [2–8]. These observations are
consistent with the extensive tissue damage and cell death seen in
autopsy material from fatal human cases [9]. Tissue damage may
occur through apoptosis and/or necrosis. Various components of
the bacterial cell wall are capable of activating proinflammatory
response, notably the meningococcal lipooligosaccharide (LOS),
the major structural component of the outer membrane.
Apoptosis plays an important role in the pathogenesis of several
infectious agents that induce or block this process [10–14].
Pathogenic Neisseriae have been shown to induce the expression of
apoptosis-related genes and to trigger apoptosis in different cell
types [15–19]. However, the mechanisms leading to this
programmed cell death are still poorly understood. Interestingly,
conflicting evidences exist on the ability of the neisserial porin
PorB to induce or to protect cells from apoptosis [16,17,20].
Moreover, meningococci-cell interaction is complicated by the
high variability of meningococcal isolates. Multilocus sequence
typing (MLST) analysis classifies meningococcal isolates according
to polymorphisms in seven housekeeping genes. Meningococcal
isolates can be clustered into clonal complexes comprising closely
related isolates varying by no more than two loci [21]. Molecular
epidemiology studies comparing the overall diversity between the
pathogenic and carriage population, show that isolates from
asymptomatic carriage are more diverse than those from invasive
disease [22,23]. Despite the diversity of carried meningococci, only
a limited number of clonal complexes, termed the hyper-invasive
lineages, are responsible for most reported disease [22–24]. Among
theseclonalcomplexes,isolatesbelongingto theclonalcomplex ST-
11 seem to be significantly associated with the disease and rarely
found in carriers [22]. Moreover, we have recently shown that
isolates of the ST-11 clonal complex positively correlated with fatal
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epithelial cells, disregarding their serogroups [25].
The aim of this work was to explore the apoptosis pathway
induced by hyper-invasive ST-11 isolates of N. meningitidis in
comparison to non invasive carriage isolates.
Results
Prevalence of cytopathogenicity among ST-11
pathogenic and carriage isolates of Nm
We selected ten pathogenic meningococcal isolates of the
sequence type ST-11 (ST-11/ET-37 complex) that belong to
different serogroups (B, C, and W135). Eight carriage isolates of
different serogroups belonging to different clonal complexes were
also included (Table 1). We first explored the cytopathic effect of
these isolates to Hec-1-B epithelial cells. All disease isolates were
cytopathic to Hec-1-B cells particularly after 9 h of infection,
regardless their serogroups. In contrast, none of the carriage
isolates tested was cytopathic (Table S1). This cytopathic effect was
mainly due to induction of apoptosis in infected cells. Indeed, all
the ST-11 pathogenic isolates significantly induced apoptosis in
infected cells as estimated by FITC-conjugated Annexin V staining
and flow cytometry (FACS) analysis (Figure 1 and Table S1).
However, FITC-conjugated Annexin V staining in cells infected
with carriage isolates was comparable to that of uninfected control
cells. All the eighteen tested isolates grew similarly in the medium
of infection (data not shown). This excludes a possible effect of
differential bacterial growth on apoptosis. The induction of
apoptosis was further confirmed by fluorescence microscopy.
Hec-1-B cells were infected with the pathogenic isolate LNP19995
or the carriage isolate LNP21019, both expressing the red
fluorescent protein DsRed, and were stained with FITC-Annexin
V 9 h post-infection. As a positive control, cells were treated with
1 mM staurosporine (STRP). We found that similarly to STRP,
LNP19995 efficiently induced cells to become apoptotic as
revealed by FITC-Annexin V staining (Figure 2A). In contrast,
Hec-1-B cells infected with the carriage isolate LNP21019 were
resistant to staining with Annexin V after the same period of
infection (Figure 2A). To further confirm that this alteration was
due to apoptotic cell death, a number of apoptosis-specific assays
were performed. Caspase-3 activity was detected in cell lysates of
Hec-1-B infected with the ST-11 pathogenic isolates. This activity
was blocked by the caspase-3-specific inhibitor DEVD (N-acetyl-
Asp-Glu-Val-Asp). In contrast, a basal level of caspase-3 activity
similar to uninfected cells was observed in cells infected with the
non-cytopathic isolates (Figure 2B and Table S1). Further
evidence of apoptosis was provided by the distinct presence of
DNA laddering effect when genomic DNA was resolved by
agarose gel electrophoresis. This laddering effect was absent in
cells infected with carriage isolates as in untreated control cells
(Figure S1). Other epithelial cell lines behave similar to Hec-1-B
cells. Indeed, the pathogenic isolate LNP19995 but not the
carriage isolate LNP21019, was able to induce apoptosis in A549
and HEp-2 human epithelial cell lines as revealed by FITC-
Annexin V staining (Figure S2). These results suggest that the
apoptotic effect of the pathogenic isolates towards infected cells is
not only restricted to Hec-1-B epithelial cell line. Taken together,
our data suggest that pathogenic meningococcal ST-11 isolates
induced apoptosis as a major cytopathic mechanism to infected
epithelial cells.
Meningococcal ST-11 isolate requires cell adhesion, but
not invasion, to induce efficient apoptosis in human
epithelial cells
Isolates used in this study (both pathogenic and carriage isolates)
are piliated and capsulated as evaluated by specific sera against pili
and capsule (data not shown). We therefore explored the impact of
these structures on the induction of apoptosis. All tested
pathogenic isolates were adherent to Hec-1-B cells (Table 1).
However, carriage isolates were heterogeneous in their adhesive-
ness to Hec-1-B epithelial cells. These observations suggest that
adhesion could be necessary but insufficient to establish a
cytopathic effect. We next compared induction of apoptosis in
human Hec-1-B epithelial cells upon infection with the wild-type
pro-apoptotic isolate LNP19995 as well as its isogenic pilus-
deficient mutant NM0706, using flow cytometry following
Annexin V staining. While the pilus-deficient mutant failed to
induce significant apoptosis, wild-type LNP19995 triggered 5 fold
increase of phosphatidylserine asymmetry breakdown as detected
by an increase in FITC-Annexin V binding within 9 h of infection.
Centrifugation of bacteria to infected cells conferred apoptotic
properties to NM0706 strain (Figure 3A and 3B), suggesting that
cell contact rather than pili expression is necessary to induce
apoptosis. Moreover, no difference in the induction of apoptosis
was observed in the presence of 10 mM cytochalasin D that blocks
bacterial invasion to Hec-1-B cells, suggesting that invasion is not
involved in this process. An isogenic capsule deficient mutant
(NM0707) was also compared to its parental strain LNP19995 and
showed a higher level of induction of apoptosis in Hec-1-B cells
than the parental strain (Figure 3A and 3B). In contrast, the
capsule-deficient isogenic mutant of the carriage isolate LNP21019
did not show any significant change in the apoptotic level
compared to the parental strain (Figure 3A). None of these tested
mutants showed growth defect when compared to their parental
strains, excluding the possibility of differential apoptosis due to
differential growth rate (data not shown). These results strongly
suggest that capsule and pili expression is not directly correlated
with induction of apoptosis.
Author Summary
Acquisition of Neisseria meningitidis often leads to
asymptomatic colonization (carriage) and rarely results in
invasive disease associated with tissue injury. The reasons
that make disease-associated isolates (pathogenic isolates)
but not asymptomatic carriage isolates able to invade the
host to establish disease are not understood. Isolates
belonging to the ST-11 clonal complex are most frequently
associated with the disease and rarely found in carriers.
These hyper-invasive isolates may be able to induce
cytopathic effects in target cells. We aimed to investigate
the cytopathic effect of meningococcal isolates on
epithelial cells using both ST-11 pathogenic isolates and
carriage isolates. We showed that cytopathic effects were
strongly associated with pathogenic isolates and infected
cells exhibited features of apoptosis. This effect is mainly
mediated by bacterial endotoxin (lipooligosaccharide) and
involved an autocrine signaling mechanism of secreted
TNF-a through its receptor TNF-RI. In contrast, carriage
isolates down-regulate TNF-RI on the surface of infected
cells by increasing TNF-RI shedding into the medium. We
suggest that chelating secreted TNF-a protects cells from
apoptosis. Our results unravel a differential modulation of
TNF-a signaling by meningococcal isolates leading to cell
survival or death and would therefore contribute to better
understanding of the duality between carriage and
invasiveness.
Apoptosis and Meningococcal Pathogenesis
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epithelial cells by the meningococcal pathogenic isolate
We next showed that sonicated extracts of the pathogenic isolate
LNP19995 was able to induce apoptosis to a similar level to that
observed with live LNP19995 bacteria. In addition, heat-killed
bacteria (60uC for 30 min) of the isolate LNP19995 were still able
to induce apoptosis in Hec-1-B cells although to a significant lesser
extent (Figure 4A). These results suggest that bacterial growth rate
does not affect the induction of apoptosis. Moreover, both
proteinaceous and non proteinaceous bacterial factors are
involved in inducing apoptosis. Indeed, both the isogenic LOS-
defective mutant Z0305 and the isogenic PorB-defective mutant
NM0401, showed reduced levels of induction of apoptosis that
were similar to that induced by heat-killed parental wild-type
bacteria (Figure 4A). Infection with the double knock out mutant
NM0705, defective in both LOS and PorB production, abrogated
apoptosis to a level comparable to uninfected control cells
(Figure 4A). Both purified LOS and PorB from the pathogenic
isolate LNP19995 were able to induce apoptosis in Hec-1-B cells
in a dose-dependent manner. The effect of LOS was abrogated by
treatment of cells with the endotoxin drug inhibitor polymixin B
(Figure 4B and data not shown). Surprisingly, purified LOS from
the carriage isolate LNP21019 induced apoptosis to a similar
extent to that purified from the pathogenic isolate LNP19995 (data
not shown). Moreover, heat-killed bacteria of the carriage isolate
also induced apoptosis (Figure 4A). Taken together, these results
suggest that the pathogenic ST-11 isolate LNP19995 induces
apoptosis, at least in part, in LOS and PorB-dependent manner.
This process was actively suppressed by the carriage isolate. To
further confirm this hypothesis, we designed a ‘‘functional’’
complementation using co-infection experiments. Hec-1-B cells
were infected with the pathogenic isolate LNP19995 or treated
with purified LOS from the isolate LNP21019 in presence of
increasing numbers of the non-pathogenic isolate LNP21019.
Figure 4C clearly shows that apoptosis induced by the pathogenic
isolate LNP19995 or LOS treatment decreased gradually by the
co-infection of Hec-1-B cells with the non-pathogenic isolate
LNP21019 in dose-dependent manner.
The ST-11 invasive isolate LNP19995 induced apoptosis
through TNF-a–dependent and TNF-a–independent
pathways
Meningococcal LOS is a potent inducer of TNF-a [26]. TNF-a
is also known to trigger apoptosis of a diverse range of cells in vitro
[27]. Surprisingly, both the pathogenic isolate LNP19995 and the
carriage isolate LNP21019 as well as purified LOS, were shown to
induce secretion of TNF-a (Figure 5A). However, only the
pathogenic isolate LNP19995 and purified LOS were able to
Table 1. N. meningitidis isolates used in this study and their characteristics.
Isolate Clonal Complex Phenotype Isolation Site Adhesion (%) Invasion (%)
Invasive LNP13143 ST-11 W135: 2a: P1.5, 2 CSF 29.066.8 1.260.4
LNP17592 ST-11 W135:2a: P1.5, 2 Blood 33.067.7 2.860.5
LNP19008 ST-11 C: 2a : P1.5, 2 Blood 34.0613.0 9.161.3
LNP19995 ST-11 W135: 2a: P1.5, 2 CSF 32.068.6 4.860.1
LNP20342 ST-11 B: 2a: P1-5, 2 CSF 33.060.7 2.660.8
LNP20553 ST-11 C: 2a: P1.5 CSF 25.063.7 2.861.9
LNP21515 ST-11 C: 2a: P1.5 CSF 32.063.4 4.861.0
LNP21678 ST-11 C: 2a: P1.5 Blood 43.068.8 12.461.5
LNP21996 ST-11 B: 2a: P1. 5 Blood 41.0613.0 15.061.2
LNP24198 ST-11 C: 2a: P1.7,1 Blood 40.562.1 4.660.8
Carriage LNP16239 NA
(1) (ST-1117) B: NT
(2):N S T
(3) Expectoration 4.067.0 2.261.4
LNP10820 ST-5 A: 4: P1.9 Expectoration 31.069.0 5.562.3
LNP18166 ST-22 W135: NT: NST Expectoration 37.063.0 4.160.2
LNP1288 ST-32 B: 14: P17. 16 Nasopharynx 31.069.0 5.562.3
LNP1934 ST-32 B: 14: P17. 16 Nasopharynx 10.062.1 2.261.4
LNP3503 ST-32 B: 14: P1. 7, 16 Nasopharynx 6.062.3 3.961.1
LNP21019 ST-35 B: NT:P1.14 Expectoration 34.0611.2 6.863.6
LNP20642 ST-334 C: NT: NST Expectoration 6.061.0 6.762.5
Mutant strains Characteristics
NM0401 Isogenic mutant of the pathogenic isolate LNP19995, deficient in PorB expression (porB::erm), EryR
NM0705 Isogenic mutant of the pathogenic isolate LNP19995, deficient in LOS and PorB production (lpxA::aph3’/porB::erm), KanR EryR
NM0706 Non-piliated isogenic mutant of the pathogenic isolate LNP19995, deficient in pilin (pilE::aph3’), KanR
NM0707 Non-capsulated isogenic mutant of the pathogenic isolate LNP19995 (ctrA::aph3’), KanR
Z0305 Isogenic mutant of the pathogenic isolate LNP19995, deficient in LOS production (lpxA::aph3’), KanR
NM0813 Non-capsulated isogenic mutant of the carriage isolate LNP21019 (ctrA::aph3’), KanR
(1)NA: not assigned to major clonal complex.
(2)NT: non-typeable.
(3)NST: non-subtypeable.
doi:10.1371/journal.ppat.1000405.t001
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reduced using anti–TNF-a neutralizing antibody (Figure 5B, left
panel). Similar results were obtained using A549 and HEp-2
epithelial cell lines (Figure S2). However, induction of apoptosis by
TNF-a in these cell lines required cyclohexemide (CHX)
treatment, an inhibitor of eukaryotic protein synthesis (Figure
S2). The decrease of apoptosis in Hec-1-B cells challenged with the
LOS-devoid mutant Z0305 correlated with the decrease of
released TNF-a (Figure 5A). The remaining apoptotic activity of
this mutant was insensitive to anti–TNF-a neutralizing antibody
(Figure 5B, left panel). In contrast, the residual induction of
apoptosis in Hec-1-B cells when infected by the PorB-deficient
mutant NM0401 (Figure 5A) was abolished in presence of anti–
TNF-a neutralizing antibody compared to cells treated with an
Figure 1. Flow cytometric analysis of Hec-1-B epithelial cells following meningococcal infection. Confluent Hec-1-B cell monolayers were
infected with the indicated pathogenic ST-11 or carriage isolates for 9 h or left uninfected (control). A positive control for apoptosis, cells were
treated for the same period with 1 mM STRP. After washing and Annexin V– and PI-staining, cells were analyzed by flow cytometry. Outset numbers in
the top of each plot, show percentages of cells in the quadrant. Early apoptotic cells (Annexin V
+/PI
2, green population), dead cells (Annexin V
2/PI
+,
red population) and late apoptotic/necrotic cells (Annexin V
+/PI
+, grey population). Data are representative of at least three independent experiments
with similar results.
doi:10.1371/journal.ppat.1000405.g001
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infection of Hec-1-B cells with the wild-type isolate LNP19995 or
the LOS-deficient mutant Z0305 was associated with an alteration
of the mitochondrial membrane potential (MMP). This alteration
was not affected by an anti–TNF-a antibody. Moreover, this
alteration was neither observed when infection was performed
using PorB-deficient mutants (NM0401 and NM0705) nor upon
TNF-a treatment. (Figure 5B, right panel). Taken together, these
Figure 2. Analysis of apoptotic Hec-1-B cells by immunofluorescence microscopy and caspase-3 activity. (A) Hec-1-B epithelial cells
were infected with the pathogenic isolate LNP19995 (Red) or the carriage isolate LNP21019 (Red). As controls, cells were left uninfected (negative
control) or treated with STRP (positive control). Nine hours later, cells were fixed and stained with FITC-Annexin V (green) and DAPI (nuclei staining,
blue) and observed under fluorescence microscope. Left panels represent images taken with low magnification (620) and right panel are merged
images taken with high magnification (6100). Green arrows indicate Annexin V positive cells. Red arrowheads indicate bacteria. BF: Bright field. Scale
bars 20 mm and 10 mm for magnifications 620 and 6100, respectively are shown. (B) The pathogenic isolate LNP19995 but not the carriage isolate
LNP21019 activates Caspases-3 in Hec-1-B epithelial cells. Cells were infected with either isolate, treated with STRP (positive control) or left untreated
(negative control). Cells were harvested 9 h post-infection, lysed and the caspase-3 activity was determined. The specificity of activity was monitored
using caspase-3 specific inhibitor DEVD added 2 h prior to infection. The activity is expressed as arbitrary fluorescence units/mg protein/h. All
samples were run in triplicate in each experiment. The results shown are representative of three independent experiments, and are expressed as
mean6SD (* indicates P,0.001).
doi:10.1371/journal.ppat.1000405.g002
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PLoS Pathogens | www.plospathogens.org 5 May 2009 | Volume 5 | Issue 5 | e1000405Figure 3. Effect of pili and capsule on apoptosis. (A) Hec-1-B epithelial cells were infected for 9 h with the pathogenic isolate LNP19995 (WT), or
the isogenic mutants NM0706 (non-piliated) and NM0707 (unencapsulated), the non-pathogenic isolate LNP21019, or the unencapsulated isogenic
mutant NM0813. In some experiments, the non piliated mutant NM0706 was directly centrifuged on cells or cells were treated with 10 mM
cytochalasin D prior to infection with the WT strain. Cells were harvested, stained with FITC-Annexin V and PI, and submitted to FACS analysis. Inset
numbers indicate the percentage of apoptotic population (green population). (B) Quantification of the results shown in A from three individual
experiments. The data in (A) are from one of three independent experiments that yielded similar results and values in (B) are the mean6SD.
doi:10.1371/journal.ppat.1000405.g003
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PLoS Pathogens | www.plospathogens.org 6 May 2009 | Volume 5 | Issue 5 | e1000405Figure 4. LOS and PorB are required for induction of apoptotic cell death by the pathogenic isolate LNP19995. (A) Hec-1-B cells were
infected with live or killed LNP19995 and LNP21019 or the isogenic mutants of the isolate LNP19995 defective in PorB (NM0401), LOS (Z0305) or both
PorB and LOS (NM0705). Apoptosis was measured by FITC-Annexin V/PI double staining after 9 h of infection. Uninfected cells were used as negative
control. The data are representative of three different experiments, and error bars represent the standard deviations of triplicate samples. (B) Purified
LOS induces apoptosis in a dose-dependent manner. Cells were treated at different concentrations with LOS for 9 h in absence (2) or presence (+)o f
1 mM polymixin B (PMB). The percentage of apoptotic cells was determined using the ApoPercentage kit. Untreated (MOI=0) cells served as the
Apoptosis and Meningococcal Pathogenesis
PLoS Pathogens | www.plospathogens.org 7 May 2009 | Volume 5 | Issue 5 | e1000405negative control. Numbers in the bottom of histograms indicate the MOIs corresponding to the amount of LOS used. (C) The non-pathogenic isolate
LNP21019 actively inhibits the apoptosis induced by LOS or the pathogenic isolate LNP19995. Cells infected with LNP19995 at MOI 10 (dark bars) or
equivalent amounts of LOS purified from LNP21019 (grey bars) were co-challenged with an increasing MOI of the isolate LNP21019. After 9 h, cells
were harvested and stained with FITC-Annexin V and PI. Numbers under histograms indicate LNP21019 to cell ratio. The data are the mean6SD of
three separate experiments (** indicates P,0.01 and * indicates P,0.05).
doi:10.1371/journal.ppat.1000405.g004
Figure 5. Analysis of TNF-a secretion and bioactivity. (A) Quantitation of TNF-a in culture supernatants of Hec-1-B cells infected with the
indicated strains. Cells were infected with the indicated strains, treated with LOS, or left untreated, and culture supernatants were collected at 9 h
post-infection and assayed for TNF-a secretion by ELISA. Shown are mean6SD of two representative experiments. (B) Left panel: Competitive
inhibition of apoptosis by an anti–TNF-a neutralizing antibody. Hec-1-B cells were infected, or treated with TNF-a for 9 h in presence of either an
anti–TNF-a neutralizing antibody (closed bars) or an isotype-matched irrelevant antibody (Irr Ab, open bars). Cells were harvested and stained with
FITC-Annexin V and PI before FACS analysis. Data are the mean6SD of three independent experiments. Right panel: LNP19995 affects the
mitochondrial membrane potential (MMP) in PorB-dependent, TNF-a-independent manner. Cells were infected as described previously. After 9 h of
incubation, cells were harvested and the mitochondrial membrane potential damage was performed using DiIC1(5) dye staining and FACS analysis.
Acquisition was performed on 10,000 events. Measurements are representative of three independent experiments. (C) The non-pathogenic carriage
isolate LNP21019 altered TNF-a bioactivity. Culture supernatants from Hec-1-B cells at 9 h after infection with LNP19995, LNP21019 or LOS treatment,
were assayed for TNF-a bioactivity by measuring cytotoxicity for L929 mouse fibroblasts. Dilutions of recombinant human TNF-a (rhTNF-a) were used
as internal standard. The specificity of TNF-a bioactivity was monitored by incubation of Hec-1-B cultures in presence of specific anti–TNF-a
neutralizing or irrelevant (Irr) antibodies. Data are mean6SD from three independent experiments. The P values are shown.
doi:10.1371/journal.ppat.1000405.g005
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through both an extrinsic pathway involving LOS induction of
TNF-a and an intrinsic pathway involving PorB.
To understand why the non-pathogenic isolate LNP21019 did
not induce apoptosis despite the similar release of TNF-a as the
pathogenic isolate LNP19995, the bioactivity of secreted TNF-a
was evaluated using the cell line L929 as described in Materials
and Methods. Bioactive TNF-a was only detected when Hec-1-B
cells were infected by the pathogenic isolate LNP19995 and
purified LOS and was specifically reduced by anti–TNF-a
neutralizing antibody (Figure 5C).
Bioactive TNF-a–induced apoptosis in epithelial cells
infected by ST-11 meningococcal isolate through TNF-RI
receptor signaling
We therefore explored the mechanism leading to alteration of
TNF-a bioactivity upon infection with the carriage isolate. TNF-a
induces apoptosis through signaling with its death domain-
containing receptor TNF-RI [28]. We next showed, using FACS
analysis, that after 9 h of bacterial infection a sustained increase in
TNF-RI staining was only observed at the surface of Hec-1-B cells
infected with LNP19995 but not at the surface of Hec-1-B cells
infected with LNP21019 (Figure 6A). Surface expression of TNF-
RII, another receptor belongingto TNF-a receptor superfamily but
lacking the death domain, remained unaffected (Figure 6A bottom
panel). We complemented our flow cytometry studies by immuno-
fluorescence microscopy to visualize the altered surface expression
ofTNF-RIinHec-1-BcellsinfectedwithLNP21019.Monolayersof
Hec-1-B cells were infected with GFP-expressing LNP21019 or
LNP19995 and were stained for TNF-RI at 9 h post-infection. As
TNF-a treatment,cellsinfected with LNP19995 exhibitedincreased
surfacestainingofTNF-RIcomparedtouninfectedcells.Incontrast,
cells infected with LNP21019 showed low level surface staining
pattern similar to uninfected cells (Figure 6B).
Pre-incubation of Hec-1-B cells with anti-TNF-RI monoclonal
antibody (mAb), but not with anti-TNF-RII, significantly reduced
apoptosis induced by the isolate LNP19995 and TNF-a compared
to an irrelevant antibody (,23% decrease). No changes were
observed after infection with the carriage isolate LNP21019
(Figure 6C). Under all tested conditions, antibody treatment did
not affect the adhesion levels of meningococcal isolates (data not
shown). Taken together, these data suggest that TNF-RI may be
involved in epithelial cell death induced by pathogenic isolates.
The meningococcal carriage isolate, but not the
pathogenic ST-11 isolate, increased shedding of TNF-RI
receptor
The reduction of TNF-RI cell surface expression by the carriage
isolate did not seem to result from transcriptional down-regulation
of its encoding gene TNFRI. RT-PCR analysis showed that TNFRI
was up-regulated upon TNF-a stimulation compared to uninfect-
ed cells. Surprisingly, bacterial challenge brought about marked
and comparable up-regulation in mRNA levels (Figure 7A).
Neither the expression of TNF-RII encoding gene (TNFRII) nor
the level of expression of b-actin encoding gene (internal control)
showed any alteration under the tested conditions (Figure 7A).
Moreover, FACS and Western blot analysis in permeabilized cells
after 9 h of infection further showed that intracellular amounts of
TNF-RI increased similarly in cells infected with each isolate
compared to uninfected cells (Figure S3). To explain the low level
of surface expression of TNF-RI in cells infected with the carriage
isolate, we monitored the level of soluble receptor (sTNF-RI)
formation. Indeed, TNF-RI is known to decrease from the cell
surface by shedding of the extracellular domain into surrounding
environment leading to formation of sTNF-RI [29–31]. Superna-
tants from Hec-1-B infected cell cultures were collected 2, 4, 6,
and 9 h post-infection and assayed for sTNF-RI by Enzyme-
Linked ImmunoSorbent Assay (ELISA). While low levels of
sTNF-RI were detected in uninfected cells over time, the level of
sTNF-RI strongly increased in a time dependent manner in cells
infected with LNP21019 and was 3 times higher than in cells
infected with LNP19995 at 9 h post-infection (Figure 7B). The
difference in the sTNF-RI levels was statistically significant at 6
and 9 h after infection (n=3, P,0.05). Levels of sTNF-RII
measured by ELISA did not significantly change following
infection (data not shown).
The presence of TNF-a bound to sTNF-RI in supernatants of
cell cultures infected with LNP21019 was examined by a mixed
ELISA. The TNF-a/sTNF-RI complexes were captured by
immobilized antibodies to sTNF-RI and quantified by using
antibodies to TNF-a. Detectable levels of TNF-a/sTNF-RI
complexes were found in cultures of Hec-1-B infected with both
N. meningitidis isolates and were not found in uninfected cells. The
level of complexes in the supernatant of Hec-1-B cells infected with
the carriage isolate LNP21019 was about 4 times higher than that
in the supernatant of Hec-1-B cells infected with the pathogenic
isolate LNP19995 (Figure 7C). Taken together, these results
strongly suggest that the carriage isolate LNP21019 in contrast to
the ST-11 pathogenic isolate LNP19995 provoked significant
shedding of TNF-RI that seems to chelate TNF-a in the cellular
environment. To further establish a causal relationship between
the shedding of TNF-RI and the protection from TNF-a-induced
apoptosis, Hec-1-B cells were infected with the pathogenic isolate
LNP19995 in presence of 250 pg/ml of sTNF-RI (which is similar
to the level of sTNF-RI shedded upon infection with the non-
pathogenic isolate LNP21019). Figure 7D showed that treatment
of cells with sTNF-RI led to decrease of apoptosis induced by the
pathogenic isolate LNP19995. These results strongly suggest that
the release of sTNF-RI is a potential mechanism of protection
against TNF-a-induced cell death.
Discussion
Asymptomatic carriage of N. meningitidis contrasts sharply with
invasive infections that are characterized by severe symptoms and
a major inflammatory response particularly cytokine production
and coagulopathy [32,33]. Host susceptibility is known to impact
on meningococcal disease (for review see [34,35]). Most likely, the
co-evolution between this exclusive human bacterium and its host
derived diversity in both host and bacteria [36]. Moreover, MLST
analysis revealed that a limited number of ‘‘hyper-invasive
lineages’’ are most frequently associated with meningococcal
disease [37,38] and that isolates belonging to these lineages,
particularly ST-11 isolates, are under-represented in healthy
carriers [22–24]. In a previous study we showed a positive
correlation between virulence in mice and proapoptotic effects to
epithelial cell line and isolates of the hyper-invasive lineage ST-11
[25]. We further confirmed here that ST-11 isolates from invasive
meningococcal infection are responsible for constant induction of
apoptosis in Hec-1-B epithelial cell model, in contrast to isolates
from healthy carriers. Moreover, we have previously reported that
pathogenic isolates of other clonal complexes (such as the clonal
complex ST-32) variably induced apoptosis and that correlated
with heterogeneous virulence in mice and higher diversity of
isolates compared to ST-11 isolates [25]. Indeed, well established
laboratory isolates such as the isolates MC58 and H44/76 (both
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PLoS Pathogens | www.plospathogens.org 9 May 2009 | Volume 5 | Issue 5 | e1000405Figure 6. Differential cell surface expression of TNF-RI upon infection with pathogenic and carriage isolates. (A) The non-pathogenic
carriage isolate specifically alters surface expression of TNF-RI. Hec-1-B cells were either left untreated in culture medium alone, treated with TNF-a,o r
incubated with bacteria for 9 h. Cells were harvested and incubated with anti-TNF-RI or anti-TNF-RII specific antibodies, followed by labeling with
FITC-conjugated secondary Abs. Samples were washed and fixed in 2.5% paraformaldehyde before FACS analysis under non-permeabilizing
conditions. Results are expressed as the percentages of positive cells stained with the specific antibody relative to irrelevant antibody derived from
10,000 events and are indicated in each panel. The solid open histograms, unstained cells; dashed histograms, cells stained with an irrelevant isotype-
matched antibody; the grey filled histograms, cells stained with specific antibody. The data shown are representative of three separate experiments.
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apoptosis in Hec-1-B cells (data not shown).
A growing number of studies have shown that apoptosis can be
modulated (inhibited or promoted) by bacteria and protozoan
parasites (for a review see [10–13]). Recently, Schubert et al. [15]
reported up-regulation of apoptosis-related genes (bad, bak, asp, and
immediate-early response gene 1) in meningococcal infected cells.
Further analyses confirmed that cells displayed several hallmarks
of apoptosis in response to meningococcal infection, namely,
phosphatidylserine translocation and activation of caspase-3 and
AMP-activated protein kinase.
Meningococcal adhesion but not invasion seems to be necessary
for the induction of apoptosis. The initial contact with the host
cells is brought by pili, where a strong association of the pathogen
to the cell takes place [39]. Our results indicate that adhesion
contributes to induce apoptosis of cells infected with pathogenic
isolates. This could occur through increasing local delivery of
bacterial factors (such as LOS and PorB) leading to apoptosis of
infected cells. In favor of this explanation is the fact that greater
and earlier apoptosis was observed in response to the capsule-
deficient mutant than in response to the wild-type strain, most
likely through unmasking bacterial surface. Moreover, the
abrogation of apoptosis in cells infected with the mutant strain
deficient in both PorB and LOS production is also in favor of this
hypothesis. In Pseudomonas aeruginosa, pili-producing strains were
essential in initiating apoptosis of human Chang conjunctiva cells
[40] and piliated enteropathogenic Escherichia coli significantly
enhanced apoptotic cell death in HeLa and Caco-2 cell lines,
compared to non-piliated mutants [41].
In the current study, we have shown that both meningococcal
LOS and PorB act independently but synergistically to induce
apoptosis in several human cell lines. Conflicting results on the role
of the major outer membrane porin, PorB, in the induction of
apoptosis in pathogenic Neisseria (N. gonorrhoeae and N. meningitidis)
have been reported [16,17,20]. Similar to our experimental
conditions, PorB-related apoptosis has been reported in absence of
serum [17]. Absence of serum did not modify the LOS effect as all
cell lines tested in this study express membrane CD14 and TLR4
([42,43] and data not shown). LOS signaling is dependent on
TLR4 [44–46], while meningococcal PorB has been described as
the ligand of TLR2 [47,48]. Although signaling through both
receptors lead to TNF-a release, our data suggest that additional
PorB-induced apoptosis to be independent from secretion of TNF-
a and may occur through the intrinsic pathway by alteration of the
mitochondrial membrane permeability [16,17].
The role of endotoxin of Gram negative bacteria (including
Neisserial LOS) in cytotopathic effects has been documented
[49,50]. The severity of meningococcal disease is thought to be
linked to the degree of the inflammatory response induced during
invasive infection [1,51]. As a potent inducer of pro-inflammatory
cytokine response, meningococcal LOS seems to play a key role in
inducing apoptosis through TNF-a [52,53]. In the current study,
we have shown that invasive isolates of N. meningitidis induced the
secretion of TNF-a and apoptosis in Hec-1-B epithelial cells that
could be abrogated by the addition of anti–TNF-a neutralizing
antibodies. A relationship between TNF-a secretion and apoptosis
in the fallopian tube has also been suggested by studies using a
mouse model of infection with a Chlamydia trachomatis mouse-
specific pneumonitis strain. Infection with this pathogen leads to a
large increase in apoptotic cells in murine oviducts, but treatment
with anti–TNF-a antibodies leads to a significant decrease in the
level of apoptosis in the upper genital tract [54].
Induction of TNF-a and subsequent apoptosis at the portal of
entry of N. meningitidis (the nasopharynx) could enhance the
invasiveness of pathogenic isolates and hence promote the hyper-
invasiveness of isolates belonging to the clonal complex ST-11.
However, the origin of locally induced TNF-a remains to be
determined. It might be produced by resident macrophages and/
or airway epithelial cells. It has been shown that TNF-a levels
were significantly higher in children with demonstrable H.
influenzae growth in nasopharyngeal cultures than in culture-
negative children [55].
An important mechanism for inducing apoptosis is the
activation of the death receptor pathway by extracellular death-
inducing ligand TNF-a, which binds to the cognate cell surface
receptor TNF-RI [56]. A major response to infectious disease is a
cytotopathic effect resulting from activation of this pathway, and
the production of TNF-a has been shown to correlate with a
cytopathic effect in infected cells [19,57]. Indeed, we were able to
demonstrate that neutralization of TNF-RI with a specific
antibody as well as pretreatment of cells with sTNF-RI provoked
a decrease of apoptosis generated by the invasive meningococcal
isolate. Moreover, we further showed that meningococcal carriage
isolate (but not pathogenic isolate) can manipulate this pathway by
increasing the shedding of TNF-RI, resulting in inactivation of
TNF-a by soluble receptor-ligand complex formation. The
mechanism of this enhancement is not yet clear. Shedding of
TNF-RI can be mediated by TNF-a converting enzyme (TACE/
ADAM 17), a metalloproteinase localized in the cytoplasmic
membrane [58,59]. A plausible explanation of the resistance to
TNF-a-induced apoptosis by the carriage non-pathogenic isolates
is the activation of TACE leading to generation of soluble TNF-a-
binding protein that binds and inhibits TNF-a bioactivity.
Chlamydia trachomatis and Streptococcus pneumoniae have been shown
to reduce the display of TNF-RI at the surface of infected HEp-2
and the airway epithelial cells, respectively through activation of
TACE [60–63]. Alternatively, an unknown TNF-RI ‘‘sheddase’’
could be expressed from the non-pathogenic isolates, to undergo
an interaction with and cleavage of TNF-RI.
The molecular basis of the pathogenicity of N. meningitidis
remains poorly understood. Full genome sequencing failed to
reveal specific components that could determine transmissibility
and colonization by carriage isolates or invasive infection by
hyper-invasive isolates. The present study provides further
evidence for the ability of pathogenic isolates of the ST-11
complex to exert cytopathic effects on epithelial cells by inducing
apoptosis [25]. Our data strongly suggest that invasiveness of
isolates of the clonal complex ST-11 positively correlates with the
induction of apoptosis by these isolates. At the opposite, carriage
isolates have co-evolved with human in a manner to reduce
inflammatory response and apoptosis induction that may correlate
with the state of asymptomatic carriage.
(B) Immunofluorescence analysis of TNF-RI surface expression. Cells adhering to tissue culture coverslips were incubated with TNF-a or infected with
GFP- bacteria (green) for 9 h. Cells were then fixed and stained for TNF-RI (Red) and with DAPI to visualize nuclei (blue). Labeled cells were examined
under a digital immunofluorescence microscope using low (620, upper panel) or high (6100, lower panel) magnifications. Green arrows and asterisks
indicate bacteria and nuclei, respectively. Scale Bars are 20 mm and 10 mm for magnifications620 and6100, respectively. (C) Competitive inhibition
of apoptosis by mAb to TNF-RI. Hec-1-B cells were infected or treated with TNF-a for 9 h in absence or presence of mAbs to either TNF-RI or TNF-RII or
an irrelevant antibody at a final concentration of 20 mg/ml. Cells were then assayed for apoptosis using ApoPercentage kit. Values shown are the
mean6SD of three independent experiments.
doi:10.1371/journal.ppat.1000405.g006
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PLoS Pathogens | www.plospathogens.org 11 May 2009 | Volume 5 | Issue 5 | e1000405Figure 7. Analysis of transcription and shedding of TNF-RI. (A) RT-PCR analysis of TNFRI and TNFRII expression. Hec-1-B cells were incubated in
medium alone (uninfected), stimulated with TNF-a or infected with LNP19995 (pathogenic) or LNP21019 (carriage) isolates for 9 h. Total RNAs were
isolated and equal amounts were analyzed by RT-PCR using TNF-RI, TNF-RII and b-actin specific primers. The data shown are from one of two
independent experiments that yielded similar results. (B) Levels of soluble TNF-RI (sTNF-RI) in supernatants from uninfected or infected cells.
Supernatants were cleared from bacteria and levels of sTNF-RI were determined by ELISA as described in Materials and Methods. Shown are
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Reagents and chemicals
RPMI 1640, HBSS, and trypsin-EDTA were purchased from
Invitrogen (Cergy, France). Anti-human TNF-a polyclonal
antibody (Anti hTNF-a) was from MBL (Montrouge, France).
Anti-TNF-RI monoclonal (mAb, Clone 16803) and anti-TNF-RII
polyclonal antibodies were from R & D system (Lille, France).
FITC-, Rhodamine- and HRP-conjugated secondary antibodies
were from Invitrogen. Caspase 3 Assay Kit, Polymixin B and
Staurosporine (STRP) were purchased from Sigma Aldrich (Lyon,
France). FITC-Annexin V kit was from Immunotech (Marseille,
France). ApoPercentage Apoptosis Kit was purchased from
Biocolor Ltd. (Newtownabbey, Northern Ireland, UK). DiIC1(5)
assay kit was purchased from Molecular Probes (France).
Bacterial strains and meningococcal characterization
Meningococcal clinical isolates in France are sent to the
National Reference Centre for Meningococci (NRCM) for full
determination and typing. Bacteria were grown in GCB medium
with Kellogg supplements [64]. Phenotypes (serogroup: serotype:
serosubtype) and MLST genotypes were determined as previously
described [21]. Sequence types (ST) and clonal complexes were
assigned using the Neisseria MLST database (http://pubmlst.org/
neisseria). All N. meningitidis strains used in this study and their
characteristics are listed in Table 1. The Pilin-deficient mutant
strain NM0706 was generated by transforming the wild type strain
LNP19995 with the genomic DNA of the previously described
strain pilE::aph3’ [65]. The isogenic mutants Z0305 devoid of LOS
(lpxA::aph3’) was obtained by transforming the wild type strain
LNP19995 with genomic DNA isolated from the previously
described mutant strain Z0204 [38]. Isolates were selected on
GCB plates supplemented with 100 mg/ml of kanamycin. To
construct the non-capsulated mutant NM0707 and PorB-deficient
mutant strain NM0401, open reading frame of either ctrA or porB
genes were PCR-amplified from the pathogenic isolate LNP19995
genomic DNA using the primer sets CtrA-1F/CtrA-100R and
PorB0-F/PorB-100R, respectively (Table 2). PCR fragments were
cloned into pGEMH-T Easy (Promega), generating pGEM-CtrA
and pGEM-PorB recombinant vectors, respectively. Blunt-ended
PCR-generated cassettes aph3’ (conferring resistance to kanamy-
cin) and erm (conferring resistance to erythromycin) were inserted
into the blunt-ended unique sites pmlI and KpnI which cut within
ctrA and porB respectively, resulting into the recombinant vectors
pGEM-ctrA::aph3’ and pGEM-porB::erm, respectively. These
recombinant vectors were separately introduced into LNP19995
and transformants were selected on kanamycin- or erythromycin-
supplemented GCB agar plates, respectively. The strain NM0705
inactivated in both porB and lpxA genes was generated by
transforming the genomic DNA of Z0305 strain (lpxA::aph3’)i n
the strain NM0401 (porB::erm). Positive clones were selected on
GCB agar plates supplemented with 100 mg/ml kanamycin and
15 mg/ml erythromycin. To construct the non-capsulated mutant
strain NM0813, ctrA was PCR-amplified from the genomic DNA
of LNP21019 using the primers 0801-Fw/0801-Rev (Table 2) and
cloned into pGEM-T easy plasmid. The blunt-ended aph3’ cassette
was then inserted into the pmlI restriction site. The resulting
recombinant vector was transformed into the parental strain
LNP21019 and transformants were selected onto GCB agar plates
supplemented with 100 mg/ml kanamycin. All knock-out mutants
were confirmed by PCR and Southern blotting. To rule out the
possibility that inserted cassettes may have a polar effect, RT-PCR
analysis were performed to monitor the expression of genes
downstream the inactivated target. The absence of pilin expression
from the mutant NM0706 and the absence of capsule expression
from the mutants NM0707 and NM0813 were further confirmed
by immunolotting using specific polyclonal sera. Silver stained
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and ELISA were further used to confirm the absence of
LOS and PorB expression from corresponding mutants.
Construction of green and red fluorescent Nm strains
The EGFP and DsRed-N1 encoding genes (ClonTech) were
amplified using the primers EGFP-Fw/EGFP-Rev and Red-Fw/
Red-Rev, respectively. Both forward primers harbor BamHI
restriction site and reverse primers harbor HindIII restriction site
as adapters to facilitate the cloning (Table 2). EGFP and DsRed
fragments were subcloned into the previously described pAD3
vector [66] restricted with BamHI and HindIII, resulting in
recombinant vectors pCRG-GFP and pCRG-Red, respectively.
The 400 bp blunt-ended promoter region of porB amplified using
the primers PorB3/PorB4 (Table 2) was inserted into BamHI site of
pCRG-GFP and pCRG-Red placing both EGFP and DsRed
under control of the constitutive meningococcal promoter porB.
The resulting vectors were called pCV1 and pCV3, respectively.
Blunt-ended aph3’ cassette was then inserted into the sites ClaIo f
pCV1 and pCV3 downstream EGFP and DsRed to produce the
vectors pCV2 (PporB-EGFP) and pCV4 (PporB-DsRed), respectively.
Plasmids pCV2 and pCV4 were separately transformed into the
isolates LNP19995 and LNP21019. Fluorescence of transformants
was confirmed using immunofluorescence microscopy and flow
cytometry. One isolate of each transformation was selected and
designated LNP19995-GFP (/Red) and 21019-GFP (/Red). These
transformants were used in indicated experiments.
Cell lines and infection
The human endometrial carcinoma Hec-1-B, the respiratory
A549 and the laryngeal carcinoma HEp-2 epithelial cell lines and
the mouse fibroblasts L929 cell lines were from American Type
Culture Collection (Manassas, VA). The human cell lines (Hec-1-
B, A549 and HEp-2 cells) and the L929 cells were maintained at
37uC under 5% CO2 humidified atmosphere in RPMI 1640 and
DMEM, respectively, supplemented with 10% heat-inactivated
fetal bovine serum (FBS). Cells were seeded in 24- or 96-well
culture plates, at a density of 5610
5 or 5610
4 cells/well. Infection
was carried out at bacteria to cell ratio of 10: 1 unless otherwise
specified. All infection experiments and treatments were carried
out in absence of serum to avoid the interference of the serum with
PorB [17]. When indicated, cells were incubated with 1 mM STRP
(used as positive control for apoptosis) or purified LOS equivalent
mean6SD of triplicate values from one representative experiment of two. (C) Concentration of TNF-a bound to sTNF-RI (representative for TNF-a-
sTNF-RI complexes) in cultures of Hec-1-B uninfected (control) or cells infected with LNP19995 or LNP21019. TNF-a-sTNF-RI complexes were assayed
by mixed ELISA (see Materials and Methods) of supernatants harvested 9 h after infection. The data presented are mean6SD of three independent
experiments. (D) Soluble TNF-RI (sTNF-RI) inhibits apoptosis induced by LNP19995 isolate. Cells were incubated alone or infected with either
LNP19995 or LNP21019 for 9 h in the presence or in the absence of 250 pg/ml of sTNF-RI. After staining with FITC-Annexin V and PI, apoptotic cells
were analyzed by FACS. Inset numbers represent the percentage of each population in the quadrants. Data are representative of two independent
experiments which yielded similar results.
doi:10.1371/journal.ppat.1000405.g007
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alone or in combination with 20 mg/ml cycloheximide. For
antibody neutralizing experiments, cells were co-incubated for the
indicated time with 100 mg/ml of the specific neutralizing
antibody or isotype-matched irrelevant IgGs, or with 250 pg/ml
of sTNF-RI (Monosan, France). Cells were then carefully washed
several times with PBS before further analysis
Adhesion assay and cytopathic effect determination
Adhesion assay was performed as described previously [66].
Cell viability was measured by Naphthol blue black (NBB) staining
assay [67]. Cells infected in 96-well plates for the indicated time
points as described previously, were stained with NBB solution
(0.05% NBB in 9% acetic acid with 0.1 M sodium acetate) for
30 min at room temperature. The wells were washed three times
with PBS to remove the free dye and fixed in 10% formalin for 5–
10 min. The attached dye was resolved with 150 mlo f5 0m M
NaOH. The absorbance at 620 nm was measured by using a
Multiskan Ascent Autoplate reader (Thermo Scientific, France).
The percent of cytopathic effect was calculated as (1- A620 nm of
infected cells/A620 nm of uninfected cells)6100.
Analysis and quantitative measurement of apoptosis
Annexin V assay. Annexin V specifically binds to phosphati-
dylserine, a plasma membrane lipid that rapidly relocalizes from
the inner leaflet to the outer leaflet in cells that are undergoing
programmed cell death (apoptosis). Concomitantly, the extent of
overall cytotopathogenicity was measured by the standard PI
staining. Co-staining with Annexin V and PI allows differentiation
of viable cells (Annexin V
2,P I
2) from early apoptotic cells
(Annexin V
+,P I
2) and late apoptotic cells (Annexin V
+,P I
+). Cells
infected in 24-well tissue culture plates as described earlier, were
harvested using cold PBS/0.02% EDTA and washed twice in
PBS. Double staining with FITC-Annexin V and Propidium
iodide (PI) was carried out using the FITC-Annexin V kit,
according to the manufacturer’s recommendations and then
analyzed by FACS. When indicated, apoptosis was also quantified
using the ApoPercentage Apoptosis Kit according to the
manufacturer’s instructions.
Assay for mitochondrial permeability transition (MPT): To
determine variations of mitochondrial permeability transitions
(MPT), as indicative of apoptosis, cells were stained with the
potential-sensitive dye 1,19,3,3,39,39-hexamethylindodicarbo-
cyanine iodide (DiIC1(5)) for flow cytometric analysis, as
recommended by the manufacturer (Molecular Probes). This dye
is reportedly only incorporated into mitochondria with intact
membrane potential. After 20 min incubation with the dye at
room temperature and darkness, cells were washed and analyzed
by flow cytometry. Cells with high fluorescence intensity for
DiIC1(5) were considered as living cells. Cells with low fluorescence
intensity for DiIC1(5) were considered apoptotic cells.
Fluorometric analysis of caspase-3 activity. Following infection
or STRP treatment, cells were harvested and processed for
Table 2. Primers used in this study.
Primer Sequence Characteristics
CtrA-1F 59-CGTCACGCAGTATTATTATTGTGTGTGGAAG-39 Coding strand of ctrA gene of serogroup W135
CtrA-100R 59-CTGTTCGCGCCACTGGTAACC-39 Non-coding strand of ctrA gene of serogroup W135
0801-Fw 59-GTGTTTAAAGTGAAATTTTA-39 Coding strand of ctrA gene of serogroup B
0801-Rev 59TTAATTAGTTAAATTATTAA-39 Non-coding strand of ctrA gene of serogroups B
PorB0-F 59-TTTTCCCAGTCACGACGTTGTAATGAAAAAATCCCTGATTGCCCTGAT-39 Coding strand of porB gene
PorB-100R 59-TGTGAGCGGATAACAATTTCGAATTTGTGGCGCAG ACCGAC-39 Non-coding strand of porB gene
EGFP-Fw 59-CTGGGATCCTAAGGAAGCCCACCATGGTGAGCAA-39 Coding strand of egfp, harboring BamHI adapter (italic) and the
SD sequence (Bold)
EGFP-Rev 59-CCCAAGCTTTTATCTAGATCCG-39 Non-coding strand of EGFP gene harboring HindIII adapter (Italic)
Red-Fw 59-CTGGGATCCTAAGGAAGCTCCACCATGGCCTCCTC-39 Coding strand of DsRed gene harboring BamHI adapter (italic)
and the SD sequence (Bold)
Red-Rev 59-CCCAAGCTTTAGAGTCGCGGCCGCTACAG-39 Non-coding strand of DsRed gene) harboring HindIII adapter
(Italic)
PorB-3 59-GGTGCTGAAGCACCAAGTGA-39 59 of porB promoter region
PorB-4 59-GGCAATCAGGGATTTTTTCA-39 39 of porB promoter region
KM-6 59-CCCAGCGAACCATTTGAGG-39 Coding strand of kanamycin resistance cassette aph3’
KM-7up 59-GCCGTCTGAATGCTTTTTAGACATCTA-39 Non-coding strand of kanamycin resistance cassette aph3’, with
N. meningitidis up-take sequence (Bold)
ERAM-1 59-GCAAACTTAAGAGTGTGTTGA-39 Coding strand of erythromycin resistance cassette erm
ERAM-3 59-AGCTTGCCGTCTGAATGGGACCTCTTTAGCTTCT-39 Non-coding strand of erythromycin resistance cassette erm, with
up-take sequence (Bold)
TNFR1-Fw 59-CCCCTGGCCCCAAACC-39 Coding strand of human TNFRI cDNA
TNFR1-Rev 59-CTCCCACTTCTGAAGG -39 Non-coding strand of human TNFRI cDNA
TNFR2-Fw 59-CTCTTCCAGTTGGACT-39 Coding strand of human TNFRII cDNA
TNFR2-Rev 59-AGAATCTGAGCTCCCG-39 Non-coding strand of human TNFRII cDNA
Actin-Fw 59-CACCCCGTGCTGCTGACCGAG-39 Coding strand of human b-actin cDNA
Actin-Rev 59-CCACACGGAGTACTTGCGCTC-39 Non-coding strand of human b-actin cDNA
doi:10.1371/journal.ppat.1000405.t002
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manufacturer. After incubation at 37uC for 70 min, fluorescence
was measured at 405 nm by a microplate reader Multiskan
Ascent, (Thermo Scientific, France). Standard p-Nitroaniline
(pNA) solution was used for calculating caspase activity.
Extraction of cellular DNA and gel electrophoresis. Harvested
cells were lysed for 1 h at 50uC in lysis buffer (0.1% Triton X-100,
5 mM Tris-HCl, pH 7.5; 0.5 mM EDTA, pH 7.2) supplemented
with proteinase K (5 mg/ml) and digested for 1 h with RNase A
(0.5 mg/ml). After two phenol/chloroform (1:1) extractions, the
DNA was precipitated with ethanol, dried, resolved in TE (10 mM
Tris-Cl, pH 7.5, 1 mM EDTA pH 8), separated on a 1.5%
agarose gel and visualized under ultra-violet light after ethidium
bromide staining.
Cell surface staining and flow cytometry
To measure cell surface expression of TNF-RI, cells were
collected in HBSS containing 0.1% sodium azide (NaN3) and 1%
FBS (staining buffer). Cells were labeled with anti TNF-RI mAb,
anti-TNF-RII or irrelevant isotype-matched IgGs for 20 min.
Cells were then washed twice with staining buffer and labeled with
FITC-conjugated secondary antibody for 20 min. Cells were then
fixed in 2% paraformaldehyde in staining buffer. Samples were
analyzed using a FACSCalibur flow cytometer (BD Biosciences,
France) equipped with FITC signal detector FL1-H (excita-
tion=488 nm, green). Relative fluorescence intensities were
recorded from a total of 10,000 events. Results were analyzed
using WinMDI 2.8 software.
Fluorescence microscopy
The immunofluorescence staining was performed as described
previously [68]. Briefly, cells adherent to glass coverslips were
infected for the indicated time, then fixed in 2.5% paraformalde-
hyde in PBS and blocked with 1% normal goat serum in PBS.
Anti-TNF-RI mAb was used at 10 mg/ml and rhodamine-
conjugated goat anti-mouse IgG was used at a dilution of
1:1000. Coverslips were mounted on microscope slides in ProLong
Gold antifade reagent (Invitrogen) to minimize photobleaching.
Slides were then examined by digital confocal microscopy using
Zeiss Axio Imager. D1 fluorescent microscope coupled to
AxioCam MRm vers.3 (Carl Zeiss, Germany). Digital images
were acquired using appropriate filters and combined using the
Axiovision Rel. 4.6 software (Carl Zeiss).
Measurement of TNF-a secretion, TNF-a bioactivity, and
TNF-a/TNF-RI complex
Supernatants of infected cells were collected, cleared of bacteria
and cells by centrifugation at 14,0006g and kept frozen at 280uC
until use. The amounts of TNF-a secreted in the supernatants
were determined using the TNF-a enzyme-linked immunosorbent
assay (ELISA) kit (R&D Systems, Abingdon, UK) in accordance
with the manufacturer’s instructions. TNF-a bioactivity was
assessed by measuring cytopathic effect on L929 murine fibroblasts
cells. In brief, L929 cell monolayers cultured for 24 h in 96-well
plates (5610
5 cells/well), were overlaid with twofold serial
dilutions of culture supernatants from Hec-1-B infected cells in
RPMI 1640 supplemented with polymixin B to a final concentra-
tion of 1 mM to avoid the effect of free circulating LOS. After
incubation at 37uC for 24 h the cells were carefully washed with
PBS, and processed for NBB staining as described above.
Estimates of the concentrations of bioactive TNF-a in the
supernatants were obtained by comparison with calibration curves
established with an rhTNF-a standard. TNF-a bioactivity in
Hec-1-B supernatant samples was inhibited by anti–TNF-a Ab,
but not by control rabbit IgG, indicating that the cytopathic
activity in Hec-1-B supernatants represents TNF-a. TNF-a bound
to TNF-RI was detected in supernatants of N. meningitidis-infected
Hec-1-B cells by a mixed Ab ELISA. The supernatants were
added to 96-well microtiter plates coated with an anti TNF-RI
mAb, and, after 2 h at room temperature, the plates were washed
and incubated for 1 h at room temperature with a rabbit anti-
human TNF-a Ab (0.2 mg/ml). After washing, HRPO-conjugated
goat anti rabbit IgG (Caltag) was determined. Peroxidase activity
was determined by addition of citrate buffer and A450 was
performed using a microplate reader. Calibrated dilutions of
rhTNF-a captured by immobilized anti–TNF-a Ab were used as
an internal standard for the comparative measurements of TNF-a
complexed with TNF-RI.
RNA isolation, RT–PCR, LOS, and PorB purification and
Immunoblot
Total RNA was prepared using Total RNA isolation kit
(Biolabs, France) according to manufacturer’s recommendations.
cDNA synthesis and PCR conditions were previously described
(Deghmane et al., 2002). To assess the expression analysis of
TNFRI and TNFRII the primer pairs TNFR1-Fw/TNFR1-Rev,
TNFR2-Fw/TNFR2-Rev were used (Table 2). b-actin-Fw/b-
actin-Rev (Table 2) were used to amplify b-actin as internal
control. Controls without RNA and/or reverse transcriptase were
included in the assay. Meningococcal LOS was prepared with
similar MOIs as previously described [69]. PorB was semi-purified
as described by [16] and used in combination with 1 mM
polymixin B to prevent any effect of LOS. For Immunoblot, cells
were lysed 10 min on ice by adding RIPA lysis buffer [50 mm
Tris-HCl (pH 7.4), 150 mm NaCl, 0.25% sodium deoxycholate,
1% NP40, 0.1% sodium dodecyl sulfate and freshly added
protease Inhibitor Cocktail]. Whole cell lysates were then
centrifuged at 13,0006g for 10 min at 4uC; and supernatants
were collected to obtain protein extracts. Protein concentrations
were determined by the Bradford assay (Bio-Rad, Hercules, CA).
Fifty micrograms of extracted protein was run on SDS-PAGE and
transferred to a nitrocellulose membrane. The blots were then
probed overnight at 4uC with the relevant antibodies, washed and
probed again with species-specific secondary antibodies coupled to
HRPO and signal was detected by chemiluminescent reagents.
Statistical analysis
Data are expressed as the mean6SD of triplicate samples, and
the reproducibility was confirmed at least in three separate
experiments. Statistical analysis were performed using student t
test (two-way Annova) test, and considered significant if P,0.05.
Supporting Information
Figure S1 DNA fragmentation in Hec-1-B cells following
infection with pathogenic ST-11 isolates or carriage isolates of
N. meningitidis. At 9 h after infection, epithelial cell DNA was
extracted, separated in a 1.5% agarose gel, and stained with
ethidium bromide. The 100-bp ladder is shown. Uninfected or
STRP treated cells were used as controls.
Found at: doi:10.1371/journal.ppat.1000405.s001 (0.75 MB TIF)
Figure S2 LNP19995 but not LNP21019 induced apoptosis in
A549 and Hep-2 epithelial cell lines. Cells were treated with TNF-
a alone or in combination with CHX, or infected with either
isolate. After 9 h of incubation in presence of anti-TNF-a
neutralizing antibody (closed bars) or irrelevant antibody (Irr Ab,
Apoptosis and Meningococcal Pathogenesis
PLoS Pathogens | www.plospathogens.org 15 May 2009 | Volume 5 | Issue 5 | e1000405open bars), cells were stained with FITC-Annexin V and PI and
apoptotic cells were analyzed by FACS. Data represent the
mean6SD of three independent experiments. *** represent
P,0.001 regarding untreated cells.
Found at: doi:10.1371/journal.ppat.1000405.s002 (0.16 MB TIF)
Figure S3 Level of TNF-RI increased in infected cells. (A) FACS
analysis revealed up-regulation of intracellular level of TNF-RI at
9 h post-infection. The solid open histograms: unstained cells, the
dotted histograms: isotype control stained cells, the gray-filled
histograms anti-TNF-RI stained cells. (B) Consistently, immuno-
blot analysis showed a strong increase in the amount of TNF-RI
protein, but not TNF-RII in infected or TNF-a-treated cells
compared with uninfected cells.
Found at: doi:10.1371/journal.ppat.1000405.s003 (0.36 MB TIF)
Table S1 Summary of cytopathic and apoptotic features of
meningococcal isolates used in this study.
Found at: doi:10.1371/journal.ppat.1000405.s004 (0.05 MB PDF)
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